Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Argus Health
Merck
Chubb
US Army
US Department of Justice
Julphar
McKinsey

Generated: September 21, 2018

DrugPatentWatch Database Preview

Abraxis Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for ABRAXIS PHARM, and what generic and branded alternatives to ABRAXIS PHARM drugs are available?

ABRAXIS PHARM has one hundred and thirteen approved drugs.

There is one tentative approval on ABRAXIS PHARM drugs.

Summary for Abraxis Pharm
US Patents:0
Tradenames:63
Ingredients:60
NDAs:113

Drugs and US Patents for Abraxis Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 089186-001 Mar 28, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Abraxis Pharm LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080420-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Abraxis Pharm RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071188-001 Jul 23, 1987 DISCN No No ➤ Sign Up ➤ Sign Up
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 089189-001 Mar 28, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Merck
Cerilliant
Chinese Patent Office
Covington
Cipla
Accenture
Boehringer Ingelheim
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.